Obeticholic Acid Tablet — FDA Drug Shortage

To Be Discontinued — Intercept Pharmaceuticals

The FDA lists a drug shortage record for Obeticholic Acid Tablet (tablet) from Intercept Pharmaceuticals with status To Be Discontinued. The shortage was first posted on 09/19/2025.

Shortage Details

Status
To Be Discontinued
Company
Intercept Pharmaceuticals
Package NDC
69516-010-30
Dosage Form
Tablet
Presentation
Ocaliva, Tablet, 10 mg (NDC 69516-010-30)
Initial Posting
09/19/2025
Revised Date